BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30610813)

  • 1. The risk factors about prognosis of 142 GIST patients with recurrence or metastasis: A retrospective study of single centre in Northern China.
    Li Y; Tan B; Wu H; Xin H; Fan L; Zhao Q; Ma Z; Liu Y
    J BUON; 2018; 23(6):1855-1861. PubMed ID: 30610813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of metastasectomy for recurrent/metastatic gastrointestinal stromal tumors based on an analysis of the Kinki GIST registry.
    Sato S; Tsujinaka T; Masuzawa T; Yamamoto K; Takahashi T; Yamashita Y; Fujita J; Takagi M; Hirota S; Nishida T
    Surg Today; 2017 Jan; 47(1):58-64. PubMed ID: 27194124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A model to predict the recurrence of middle-high risk gastrointestinal stromal tumors based on preoperative fibrinogen and peripheral blood inflammatory indexes].
    Li W; Peng QW; Lin Y; Wan WZ; Zeng XY; Sun X; Yang WC; Xiong Z; Liu WZ; Tao KX; Zhang P
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):896-903. PubMed ID: 32927515
    [No Abstract]   [Full Text] [Related]  

  • 4. [A multicentre retrospective cohort study of patients with gastrointestinal stromal tumors in Shandong Province].
    Ning L; Yan W; Zhang M; Gong H; Dai Y; Jiang L; Lin H; Zhang D; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):326-30. PubMed ID: 24760638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of clinical features and prognostic factors on reoperation patients with postoperative recurrence or metastasis of gastrointestinal stromal tumor].
    Wang L; Xu W; Yao X; Yan C; Li C; Zhu Z; Liu W; Yan M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1274-1279. PubMed ID: 30506539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of preoperative factors associated with outcomes following surgical management of intra-abdominal recurrent or metastatic GIST following neoadjuvant tyrosine kinase inhibitor therapy.
    Roland CL; Bednarski BK; Watson K; Torres KE; Cormier JN; Wang WL; Lazar AJ; Somaiah N; Hunt KK; Feig BW
    J Surg Oncol; 2018 Apr; 117(5):879-885. PubMed ID: 29448300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes of diagnosis and treatment for gastrointestinal stromal tumors during a 18-year period in four medical centers of China].
    Qiu H; Zhang P; Feng X; Chen T; Sun X; Yu J; Chen Z; Li Y; Tao K; Li G; Zhou Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1265-1270. PubMed ID: 27928797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative monocyte-to-lymphocyte ratio predicts recurrence in gastrointestinal stromal tumors.
    Cananzi FCM; Minerva EM; Samà L; Ruspi L; Sicoli F; Conti L; Fumagalli Romario U; Quagliuolo VL
    J Surg Oncol; 2019 Jan; 119(1):12-20. PubMed ID: 30426498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis.
    Wang CJ; Zhang ZZ; Xu J; Wang M; Zhao WY; Tu L; Zhuang C; Liu Q; Shen YY; Cao H; Zhang ZG
    World J Gastroenterol; 2015 Jul; 21(27):8398-407. PubMed ID: 26217092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of liver metastases of gastrointestinal stromal tumors (GIST).
    Vassos N; Agaimy A; Hohenberger W; Croner RS
    Ann Hepatol; 2015; 14(4):531-9. PubMed ID: 26019040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic significance of clinicopathologic parameters in gastrointestinal stromal tumor: a study of 156 cases].
    Liang YM; Li XH; Lü YY; Lü YL; Zhong M; Pu XL; Li WM
    Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):233-8. PubMed ID: 17706113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the Japanese gastric cancer screening system on treatment outcomes in gastric gastrointestinal stromal tumor (GIST): an analysis based on the GIST registry.
    Yamamoto K; Tsujinaka T; Takahashi T; Sato S; Nishiguchi Y; Nakashima Y; Muguruma K; Hirota S; Nishida T
    Ann Surg Oncol; 2015 Jan; 22(1):232-9. PubMed ID: 25135848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics and prognosis analysis of 119 cases with giant gastrointestinal stromal tumor].
    Zhang P; Zeng X; Gao J; Liu W; Shuai X; Liu K; Liu X; Cai M; Cai K; Wang G; Tao K
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1290-1295. PubMed ID: 27928802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal Stromal Tumors Risk of Recurrence Stratification by Tumor Volume is a Best Predictor Compared with Risk Based on Mitosis and Tumor Size.
    Lino-Silva LS; Segales-Rojas P; Aguilar-Cruz E; Salcedo-Hernández RA; Zepeda-Najar C
    J Gastrointest Cancer; 2019 Sep; 50(3):513-518. PubMed ID: 29766411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of low-density lipoprotein receptor class A domain containing 4 (LDLRAD4) as a prognostic indicator in primary gastrointestinal stromal tumors.
    Xie W; Xiao H; Luo J; Zhao L; Jin F; Ma J; Li J; Xiong K; Chen C; Wang G
    Curr Probl Cancer; 2020 Dec; 44(6):100593. PubMed ID: 32507364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal stromal tumor (GIST) with liver metastases: An 18-year experience from the GIST cooperation group in North China.
    Shi YN; Li Y; Wang LP; Wang ZH; Liang XB; Liang H; Zhang L; Li B; Fan LQ; Zhao Q; Ma ZX; Zhao XF; Zhang ZD; Liu Y; Tan BB; Wang D; Wang LL; Hao YJ; Jia N
    Medicine (Baltimore); 2017 Nov; 96(46):e8240. PubMed ID: 29145240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment strategy for recurrent and metastatic gastrointestinal stromal tumors].
    Liang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):309-11. PubMed ID: 24760634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
    Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
    Basilio-de-Oliveira RP; Pannain VL
    World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal stromal tumor and isolated anterior tibial muscle metastasis as first recurrence.
    Mutlu H; Balkarlı H; Musri FY; Salim DK; Eryılmaz MK; Ünal B; Coşkun HŞ
    J Cancer Res Ther; 2015; 11(4):1037. PubMed ID: 26881647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.